Showing results (1-10 of 175) with videos related to
Sort By:
Pageof 18
Current Opinion in Pharmacology|July 11, 2009
Inflammation and colorectal cancerSarah Kraus, Nadir ArberEuropean Journal of Cancer (Oxford, England : 1990)|September 25, 2009
Screening for colorectal cancer, where are we now?Sarah Kraus, Nadir ArberDigestive Diseases (Basel, Switzerland)|November 20, 2010
Role of cyclooxygenase-2 in pathogenesis and prevention of colorectal cancerEzra Hahn, Sarah Kraus, Nadir ArberRecent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 16, 2012
COX-2 active agents in the chemoprevention of colorectal cancerSarah Kraus, Inna Naumov, Nadir ArberExpert Opinion on Medical Diagnostics|March 19, 2013
Blood-based peptide, genetic, and epigenetic biomarkers for diagnosing gastrointestinal cancersSarah Kraus, Ajay Goel, Nadir ArberCurrent Pharmaceutical Design|September 16, 2015
Can We Select Patients for Colorectal Cancer Prevention with Aspirin?Sarah Kraus, Daniel Sion, Nadir ArberExpert Review of Anticancer Therapy|October 15, 2010
Colorectal cancer chemoprevention: the potential of a selective approachOded Ben-Amotz, Nadir Arber, Sarah KrausCancer Letters|February 5, 2014
Recent advances in personalized colorectal cancer researchSarah Kraus, Ilana Nabiochtchikov, Shiran Shapira, et al.Expert Opinion on Investigational Drugs|April 9, 2010
Targeted immunotherapy for colorectal cancer: monoclonal antibodies and immunotoxinsShiran Shapira, Victoria Lisiansky, Nadir Arber, et al.The Journal of Biological Chemistry|October 7, 2011
The CD24 protein inducible expression system is an ideal tool to explore the potential of CD24 as an oncogene and a target for immunotherapy in vitro and in vivoShiran Shapira, Dina Kazanov, Samuel Weisblatt, et al.Pageof 18